City State Bank Eli Lilly & CO Transaction History

City State Bank

$272 Million
Q3 2024

A detailed history of City State Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, City State Bank holds 3,127 shares of LLY stock, worth $2.42 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

3,127

Previous 3,229 3.16%

Holding current value

$2.42 Million

Previous $2.92 Million 5.23%

% of portfolio

1.02%

Previous 1.2%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$772.14 - $960.02 $78,758 - $97,922	-102 Reduced 3.16%	3,127 $2.77 Million
Q2 2024 Jul 08, 2024	SELL	$724.87 - $909.04 $11,597 - $14,544	-16 Reduced 0.49%	3,229 $2.92 Million
Q1 2024 Apr 11, 2024	SELL	$592.2 - $792.28 $120,216 - $160,832	-203 Reduced 5.89%	3,245 $2.52 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $76,152 - $89,773	-145 Reduced 4.04%	3,448 $2.01 Million
Q3 2023 Oct 16, 2023	SELL	$434.7 - $599.3 $76,072 - $104,877	-175 Reduced 4.64%	3,593 $1.93 Million
Q2 2023 Jul 10, 2023	SELL	$350.74 - $468.98 $8,067 - $10,786	-23 Reduced 0.61%	3,768 $1.77 Million
Q1 2023 Apr 10, 2023	SELL	$310.63 - $364.82 $37,275 - $43,778	-120 Reduced 3.07%	3,791 $1.3 Million
Q4 2022 Jan 11, 2023	SELL	$321.55 - $374.67 $124,118 - $144,622	-386 Reduced 8.98%	3,911 $1.43 Million
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $12,748 - $14,528	-43 Reduced 0.99%	4,297 $1.39 Million
Q2 2022 Aug 22, 2022	BUY	$278.73 - $327.27 $6,968 - $8,181	25 Added 0.58%	4,340 $1.41 Million
Q1 2022 Jun 01, 2022	BUY	$234.69 - $291.66 $13,377 - $16,624	57 Added 1.34%	4,315 $1.24 Million
Q4 2021 Mar 23, 2022	BUY	$224.85 - $279.04 $9,668 - $11,998	43 Added 1.02%	4,258 $1.18 Million
Q4 2021 Mar 11, 2022	BUY	$224.85 - $279.04 $947,742 - $1.18 Million	4,215 New	4,215 $1.11 Million

Others Institutions Holding LLY

# of Institutions

4,012

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.

Account